Smith + Nephew Academy expands global access to professional medical education through virtual reality and other advanced simulation technologies

London And the September 21 2022 /PRNewswire/ — Smith + Nephew (LSE: SN, NYSE: SNN), the global medical technology company, announced today that it is expanding its medical education curriculum through a suite of advanced simulation technologies. Healthcare professionals can now easily access training in basic procedural skills for orthopedics, robotics and sports medicine using virtual and augmented reality, and interactive 3D games at every Smith + Nephew Academy center of excellence around the world.

Healthcare professionals globally recognize the benefits that simulation technology can provide as part of their continuing education journey. Enhancing procedural, psychomotor, and cognitive skills by simulating the decision-making process of surgeons provides an immersive learning experience that traditional training methods cannot match.

the master. Stephen Mitchell, Consultant Traumatologist and Orthopedic at University Hospitals Bristol NHS Foundation Trust recently led a Smith + Nephew hip fracture management course using virtual reality. He commented, “There is a huge opportunity with virtual reality for future training applications to drive both accelerated learning and distance training. It fully lends itself to the 2D/3D nature of trauma, arthroscopy and arthroplasty procedures.”

Recent randomized controlled trials have produced data indicating that virtual reality training programs can be a more effective way to learn orthopedic techniques than passive learning tools such as standard guided training.1 Training groups completed their assessments faster, with a higher global rating score, and showed greater retention with higher scores when retesting at two weeks.1

A recent Smith + Nephew survey of participants in a virtual reality training course concluded that they felt the workshop increased their knowledge of the surgical procedure and better prepared them for the cadaver lab due to walking through devices.2 When asked if they would like to see more virtual reality sessions as part of future medical education programmes, 90% of the participants answered “yes.”2

“Smith + Nephew’s commitment to being a world leader in medical education and improving patient outcomes is to provide a modern, interactive learning environment tailored to the needs of the healthcare professional,” he said. Cindy Walker, senior vice president of global medical education for Smith + Nephew. “Through Smith + Nephew Academy, we are actively changing the way we educate our clients around the world by keeping them informed of the latest technology, clinical content and scientific data.”

A number of educational VR units are currently available including the world’s first for arthroscopic meniscus repair which was launched earlier this year. In addition, a unit for JOURNEY II BCS Total Knee Arthroplasty using CORI robot-assisted The surgical system will be launched globally in October.

If you are a healthcare professional and would like to learn more about Smith + Nephew’s global medical education offering, please visit our booth at OSET (#110) and our global Education Unlimited platform

1. Blumstein G, Zukotynski B, Cevallos N, et al. A randomized trial of a virtual reality tool to teach the surgical technique of intramedullary tibial shaft fracture. y Teaching surg. 2020; 77 (4): 969-977
2. Smith + Nephew survey results on file

About Smith + Nephew
Smith + Nephew is a medical technology portfolio focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people’s bodies and self-belief by using technology to lift the limits of life. We call this purpose “Life Unlimited”. Our 18,000 employees fulfill this mission every day, making a difference in patients’ lives through excellence in our product range, innovation and application of new technologies across our three global franchises of Orthopedics, Sports Medicine, ENT and Advanced Wound Management.

founded in Hull, United Kingdomfounded in 1856, now operates in more than 100 countries, and has achieved annual sales of $5.2 billion in 2021. Smith + Nephew is a component of the FTSE100 (LSE: SN, NYSE: SNN). The terms “Group” and “Smith + Nephew” are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.

For more information about Smith + Nephew, please visit www.smith-
and follow us TwitterAnd the LinkedInAnd the Instagram or Facebook.

forward-looking statements
This document may contain forward-looking statements that may or may not prove to be accurate. For example, statements regarding expected revenue growth, trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as “objective,” “plan,” “intent,” “expect,” “well positioned,” “believe,” “estimate,” “expect,” “objective,” “consider,” and similar expressions are generally intended to identify data forward-looking. Forward-looking statements involve known and unknown risks, uncertainties and other significant factors that could cause actual results to differ materially from those expressed or implied by the statements. For Smith + Nephew, these factors include: risks related to the impact of COVID-19, such as depth and longevity of its impact, government and other restrictive measures taken in response to physical delays and cancellations of elective procedures, reduced capacity for procedures in medical facilities, or restricted salespeople’s access to Medical facilities, or our ability to implement business continuity plans as a result of COVID-19; Economic and financial conditions in the markets we serve, particularly those affecting healthcare providers, payers, and customers (including, but not limited to, the consequence of COVID-19); price levels for well-established and innovative medical devices; Advances in medical technology. regulatory approvals, payment decisions, or other governmental actions; Product defects, recalls or other problems with quality management systems or non-compliance with relevant regulations; litigation related to patents or other claims; Legal compliance risks and related investigative, remedial or enforcement actions; disruption to our or our suppliers’ supply chain or operations (including, without limitation, as a result of COVID-19); competition for qualified personnel; strategic actions, including acquisitions and disposals, our success in performing due diligence and evaluating and merging the acquired business; disturbances that may result from transactions or other changes we make in our business or organization plans to adapt to market developments; and many other matters that affect us or affect our markets, including those of a political, economic, commercial, competitive or reputational nature. Please refer to documents that Smith + Nephew filed with the US Securities and Exchange Commission under the US Securities and Exchange Act of 1934, as amended, including Smith + Nephew’s most recent annual report on Form 20-F, for a discussion of some of these factors. Any forward-looking statement is based on information available to Smith + Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith + Nephew qualify this warning. Smith + Nephew undertakes no obligation to update or revise any forward-looking statement to reflect any change in circumstances or Smith + Nephew’s expectations.

A trademark of Smith + Nephew. Some marks are registered with the US Patent and Trademark Office.

Smith & amp.  Nephew's logo.  (PRNewsFoto/Smith & nephew)

Smith & Nephew logo. (PRNewsFoto/Smith Nephew)



View original content for multimedia download: programming language

SOURCE Smith & Nephew plc

Leave a Comment